Rock Springs Capital Management LP Rigel Pharmaceuticals Inc Transaction History

Rock Springs Capital Management LP

$3.22 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $3.3 Million - $15.7 Million	-4,921,487 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $136,057 - $211,440	61,287 Added 1.26%	4,921,487 $14.7 Million
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $157,648 - $238,476	66,800 Added 1.39%	4,860,200 $12.9 Million
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $134,750 - $173,250	38,500 Added 0.81%	4,793,400 $17.4 Million
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $39,861 - $58,566	12,900 Added 0.27%	4,754,900 $20.6 Million
Q1 2021 May 17, 2021	SELL	$3.35 - $4.93 $2,984 - $4,392	-891 Reduced 0.02%	4,742,000 $16.2 Million
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $2.06 Million - $4.77 Million	-1,154,751 Reduced 19.58%	4,742,891 $11.4 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $560,675 - $815,166	397,642 Added 7.23%	5,897,642 $10.8 Million
Q1 2020 May 15, 2020	BUY	$1.27 - $3.0 $2,667 - $6,300	2,100 Added 0.04%	5,500,000 $8.58 Million
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $2.08 Million - $3.15 Million	1,297,900 Added 30.9%	5,497,900 $11.8 Million
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $156,000 - $252,000	75,000 Added 1.82%	4,200,000 $9.66 Million
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $455,000 - $628,250	175,000 Added 4.43%	4,125,000 $13.2 Million
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $3.89 Million - $5.65 Million	1,375,000 Added 53.4%	3,950,000 $11.2 Million
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $354,000 - $454,000	100,000 Added 4.04%	2,575,000 $9.12 Million
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $4.76 Million - $6.34 Million	1,475,000 Added 147.5%	2,475,000 $9.6 Million
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $2.18 Million - $2.57 Million	1,000,000	1,000,000 $2.54 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account